Jump to search

May 2021

UC Davis MIND Institute to host inaugural stem cell, gene therapy conference

May 11, 2021

The UC Davis MIND Institute is now accepting abstracts for its first-ever Stem Cell and Gene Therapy for Neurodevelopmental Disorders Conference. The September event will feature both in-person and virtual options and will focus on the development of treatments for genetic disorders.

UC Davis Health now enrolling children ages 12-17 for Novavax coronavirus vaccine trial

May 7, 2021

UC Davis Health will soon launch a stage 3 clinical trial for a new coronavirus vaccine for children ages 12-17 with the National Institutes of Health (NIH) and Novavax. The two-year study aims to enroll 100 participants.

April 2021

Calibrating Lactoferrin protein in milk may boost learning and protect neurons

April 29, 2021

Lactoferrin is a glycoprotein found naturally in breast milk. A study by UC Davis Professor Fredric A. Troy II found that the lactoferrin concentration in the diet has significantly different impacts on learning, brain development and neuroprotection.

PsychLight sensor to enable discovery of new psychiatric drugs

April 28, 2021

UC Davis researchers develop PsychLight, a sensor that could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse.

Promising gene therapy for Duchenne muscular dystrophy

April 28, 2021

Clinical researchers at UC Davis Health are using an innovative gene therapy approach for Duchenne muscular dystrophy, which the lead physician hopes will be a transformational treatment for children with the disease.

Celebrating translational science researchers at UC Davis

April 23, 2021

During its 16th annual CTSC Scholar Symposium, UC Davis celebrated the graduation of its newest cohort of scholars who conduct innovative applied health research.

MIND Institute study of anxiety in children with autism now includes online treatment

April 20, 2021

The UC Davis MIND Institute is now offering online treatment as part of its clinical trial known as the STAAR study. The trial will compare the effectiveness of the medication sertraline and cognitive behavioral therapy in treating anxiety in children with autism.

New test to study language development in youth with Down syndrome

April 8, 2021

A team led by UC Davis Health researchers tested and validated a new set of procedures for collecting, measuring and analyzing the spoken language of youth with Down syndrome in a naturalistic setting.

March 2021

Nexplanon birth control study seeks participants

March 9, 2021

UC Davis Health is now enrolling women in a new study to extend Nexplanon’s use to five years. Nexplanon is a contraceptive implant that is inserted under the skin of the upper arm to provide birth control. The implant is currently approved for three years of use.  

New research seeks to reduce birth injury causing shoulder, arm and hand paralysis

March 9, 2021

New study evaluates maternal and hospital factors possibly linked to risk of brachial plexus birth injury, the leading cause of infants’ upper extremity paralysis.

Enhancing California’s specialty crops

March 4, 2021

UC Davis’ Center for Precision Medicine and Data Sciences will be helping to enhance the competitiveness of California’s specialty crops thanks to a new grant.

First stem cell clinical trial for spina bifida treatment announced

March 1, 2021

A UC Davis Health team today announced the launch of the world’s first FDA-approved human clinical trial to treat the most serious form of spina bifida. The trial involves the use of stem cells, applied during a surgery before birth.

February 2021

New mini-medical school seeks to engage, serve Sacramento’s Vietnamese community

February 26, 2021

Vietnamese mini-medical school, an educational outreach effort by CTSC program and the Alzheimer’s Disease Research Center, is open for registration.

UC Davis School of Medicine scored a record year of NIH funding

February 23, 2021

In 2020, the UC Davis School of Medicine secured its highest-ever level of National Institutes of Health research funding at more than $181 million.

UC Davis Health joins Mount Sinai, Cleveland Clinic and Northwestern in grant to implement and evaluate IBD Digital Therapeutics Toolkit within EHR

February 19, 2021

UC Davis Health has joined with several of the nation’s top health systems to help launch a NIH-sponsored initiative for an new digital therapeutics toolkit targeting inflammatory bowel disease.

January 2021

Twelve COVID-19 treatments being tested at UC Davis School of Medicine

January 28, 2021

In the search for potential COVID-19 treatments, UC Davis School of Medicine is recruiting participants for more than 12 clinical trials.

UC Davis receives $3.2 million grant to study age-related macular degeneration

January 19, 2021

Glenn Yiu, an associate professor in the Department of Ophthalmology and Vision Science, has been awarded a five-year, $3.2 million grant from the National Institutes of Health National Eye Institute for a study on age-related macular degeneration, or AMD.

Fewer behavior problems in young foster care kids after PC-CARE program

January 14, 2021

A new study finds that young children in the foster care system demonstrated fewer behavior problems after participating in an innovative seven-week intervention. The program is called PC-CARE, and was pioneered at UC Davis CAARE Center.

Exposure to violence takes a toll on the socioemotional well-being of Californians

January 14, 2021

A survey of Californians finds that exposure to violence has pervasive social and emotional impacts on people, especially when firearms are involved.

Research on COVID-19 vaccine includes data from UC Davis School of Medicine

January 13, 2021

The New England Journal of Medicine published a peer-reviewed paper on the newly available Pfizer COVID-19 vaccine. It includes clinical trial data collected from UC Davis Health, the only academic medical center on the West Coast to take part in the study.

Innovative serotonin sensor to improve neurological drug development

January 11, 2021

UC Davis researchers developed and used an innovative sensor to track serotonin in the brains of mice during social interactions, fearful situations and sleep/wake conditions. Sensor can help in developing better neuropsychological drugs for depression and other conditions.

Concerns about violence increase in California amid COVID-19 pandemic

January 4, 2021

Study finds that people in California are more worried about violence during COVID-19 pandemic.

December 2020

UC Davis Health launches new COVID-19 vaccine trial

December 30, 2020

Participants are needed for a new clinical trial at UC Davis Health to test another experimental COVID-19 vaccine that could help address the global pandemic.

Stem cells: A possible treatment for severe respiratory failure, a COVID-19 complication

December 21, 2020

UC Davis Health scientists joined a landmark multicenter clinical trial to test the ability of a type of stem cells to treat patients with acute respiratory distress syndrome (ARDS), a life-threatening lung injury.

Big brains and white matter: New clues about autism subtypes

December 17, 2020

Researchers found that a long-accepted theory about brain size in some children with autism may not be true. In a separate study, they linked development of white matter with changes in autism symptom severity.

Wildfire smoke can carry microbes that cause infectious diseases

December 17, 2020

Wildfire smoke contains microbes, a fact that’s often ignored, but one that may have important health repercussions.

Risk factors for Valley fever among Hispanic California farmworkers

December 15, 2020

Valley fever exposure might be higher in certain agricultural tasks and types of crops, according to Prof. Stephen McCurdy’s research.

UC Davis Health is prepared to receive Pfizer COVID-19 vaccine

December 10, 2020

With an allotment of Pfizer’s COVID-19 vaccine to arrive as early as Monday, UC Davis Health is preparing its storage space and its employees for one of the most significant inoculation efforts in recent history.

Hydrogen peroxide keeps gut bacteria away from the colon lining

December 9, 2020

An enzyme in the colon lining releases hydrogen peroxide – a known disinfecting compound- to protect the body from gut microbial communities. The new study points to the need for a different approach to treating gut inflammation and bacterial imbalance in the colon.

Neurologist Michael Rogawski named fellow of the National Academy of Inventors

December 8, 2020

Michael Rogawski has been elected a fellow of the National Academy of Inventors, the highest professional distinction given to academic inventors, for his inventions in drug discovery and development.

UC Davis Health joins Novavax in testing a new COVID-19 vaccine

December 7, 2020

UC Davis Health launches a COVID-19 clinical trial with Novavax to test a new coronavirus vaccine. This vaccine has an important advantage: liquid state storage that allows for distribution using standard vaccine channels, unlike the Pfizer and Moderna vaccines that must be stored at subzero temperature.

Kidney and brain injuries linked to diabetic ketoacidosis

December 4, 2020

UC Davis Health experts have identified factors that make children with diabetic ketoacidosis more likely to experience acute kidney injury. The results may eventually lead to new options and better treatments for the dangerous condition. 

November 2020

Obesity affects stem cell transplants for cancer, blood disorder treatments

November 25, 2020

Led by a UC Davis Health team, researchers have found that obesity can block the benefits of a stem cell transplant when it is used for treating blood cancers and other related disorders.

School of Medicine team contributes to special issue of Birth Defects Research

November 18, 2020

A UC Davis research team, consisting of postdoctoral fellows, graduate students and undergraduates led by Chengji Zhou, professor of biochemistry and molecular medicine at the UC Davis School of Medicine, has made major contributions to the latest issue of Birth Defects Research. This issue was published online this month.

Breathing problems in teens: COVID-19 or lung injury due to vaping?

November 17, 2020

Lung injury due to e-cigarette use (EVALI) and COVID-19 share many symptoms. Providers need to get the vaping history of teenagers with unexplained breathing problems.

State stem cell agency funds clinical trial for spina bifida treatment

November 12, 2020

California’s stem cell agency awarded funding to UC Davis Health researchers for the first human clinical trial using stem cells to treat spina bifida.

Young survivors of acute myeloid leukemia have long-term complications from treatment

November 9, 2020

Adolescent and young adult patients treated for acute myeloid leukemia have a high risk of developing several long-term health complications after treatment.

Does breastfeeding lower mother’s breast cancer risk?

November 5, 2020

Less than 40% of women in the U.S. know that breastfeeding lowers breast cancer risk.

Jennifer Doudna on CRISPR, coronavirus and curiosity-driven research

November 3, 2020

2020 Nobel Laureate Jennifer Doudna gave a fascinating talk on CRISPR and its potential to improve diagnosis and treatment of COVID-19.

October 2020

The CTSC paves the way for promising medical researchers through KL2 awards

October 27, 2020

CTSC encourages medical researchers to apply now to KL2 Mentored Career Development grants.

Cord blood DNA can hold clues for early ASD diagnosis and intervention

October 22, 2020

Specific regions in cord blood DNA can help identify kids who might develop autism.

For toddlers with autism, more intervention hours are not necessarily better

October 19, 2020

Two prominent early intervention models for toddlers with autism show a very similar impact, whether delivered at 15-hours or 25-hours per week intensities.

2020 Nobel Laureate Jennifer Doudna guest speaker on CRISPR and coronavirus (Oct. 30)

October 16, 2020

2020 Nobel Laureate Jennifer Doudna guest speaker at the upcoming Distinguished Speaker Series in Research and Innovation.

NICU webcam program positively impacts parents, study finds

October 14, 2020

NICU parents feel more involved in their infant’s care, more likely to provide breastmilk to their baby when they can watch their child in the NICU, thanks to a webcam.

Can an antibody ‘cocktail’ prevent COVID-19 infection?

October 12, 2020

In a new COVID-19 clinical trial, Stuart Cohen at UC Davis Health tests monoclonal antibody combination to prevent COVID-19 in adults exposed to infected patients.

UC Davis School of Medicine and UTHealth get nearly $54 million to study the role of white matter lesions in dementia

October 5, 2020

Brain scientists from UC Davis School of Medicine and The University of Texas Health Science Center have been awarded a six-year, $53.6 million grant from the National Institutes of Health to determine the role of incidental white matter lesions, or WMLs, in dementia.

UC Davis to offer free COVID-19 testing for Central Valley farmworkers

October 1, 2020

Four UC Davis research centers will partner with 10 community organizations to offer free COVID-19 testing for Central Valley farmworkers under a new federal grant

September 2020

Complications from diabetes linked to worse memory, IQ in children

September 22, 2020

Diabetic ketoacidosis is linked to lower IQ scores and worse memory in children with type 1 diabetes.

New OSCAR Clinical Trial for potential COVID-19 therapy at UC Davis Health

September 22, 2020

Timothy Albertson leads OSCAR clinical trial at UC Davis Health for patients with COVID-19-related pulmonary complications.

Introducing COVID19questions.org

September 17, 2020

UC Davis Health is part of a a new research consortium inviting clinicians, researchers, patients and the general public to submit questions that could be answered by COVID-19 patient record data. 

New study links combination of fructose, glucose in high fructose corn syrup to heart health risks

September 17, 2020

Consuming high fructose corn syrup appears to be as bad for your health as consuming sugar in the form of fructose alone, according to a new study from researchers at the University of California, Davis. 

UC Davis applies microneedles to deliver gene therapy inside the eye

September 16, 2020

A novel approach to deliver gene therapy for retinal diseases eliminates the need for complex eye surgery and treats more damaged cells that existing methods, a team of UC Davis physicians and veterinary eye specialists has found.

New dopamine sensors could help unlock the mysteries of brain chemistry

September 14, 2020

New neurotransmitter sensors to detect and monitor different information processing acts in the brain.

New cardiology study tests a device designed to repair leaky tricuspid valves

September 8, 2020

UC Davis Health cardiologists are testing the safety and effectiveness of TriClip, a minimally invasive option for treating tricuspid regurgitation. 

Gun owner perceptions about actual firearm dangers suggest opportunities for improving gun safety

September 8, 2020

Owning a gun or living in a house with a gun linked to a lower perception of risk for gun violence.

August 2020

Gunshot injuries in California drop, but percentage of firearm deaths goes up

August 26, 2020

Despite a significant drop in gun injuries, California has experienced a substantial increase in the state’s overall death rate among those wounded by firearms.

Radiation treatment for childhood or young adult primary cancer linked to worse breast cancer-specific survival

August 26, 2020

A newly published study suggests breast cancer-related survival is decreased among patients who were treated for with radiation therapy for cancers during their youth.

UC Davis Health begins clinical trial in hopes of a COVID-19 vaccine (video)

August 20, 2020

UC Davis Health, in partnership with Pfizer Inc. and BioNTech SE began a global clinical trial for an investigational vaccine against COVID-19.

Surgical and engineering researcher wins national dialysis innovation award

August 17, 2020

Aijun Wang, a UC Davis associate professor of surgery and biomedical engineering, has been awarded a $500,000 grant to create the next generation of vascular grafts for dialysis patients with end-stage kidney disease. 

Strategies for supplementation to breastfed newborns vary widely among U.S. hospitals

August 17, 2020

A study led by UC Davis Health found considerable differences in the management of breastfed infants across U.S. hospitals, especially in terms of criteria for medically-indicated supplementation.

Pregnant mother's immunity tied to behavioral, emotional challenges for kids with autism

August 14, 2020

Children with autism born to mothers who had immune conditions during their pregnancy are more likely to have behavioral and emotional problems, a UC Davis Health study has found. Offspring sex may also interact with maternal immune conditions to influence outcomes, particularly in terms of a child's cognition.

New funding for firearm violence research in California

August 14, 2020

The UC Firearm Violence Research Center has awarded more than $250,000 in unique firearm violence research projects to seven teams of investigators.

UC Davis researchers find a way to help stem cells work for the heart

August 13, 2020

Blocking an enzyme — soluble epoxide hydrolase, or sEH — linked with inflammation makes it possible for stem cells to repair damaged heart tissue.

During the COVID-19 pandemic, mothers can still safely breastfeed with appropriate precautions

August 13, 2020

Mothers with confirmed or suspected COVID-19 can safely breastfeed with appropriate precautions and the benefits of breastfeeding outweigh potential risks, according to a review article published in the American Journal of Perinatology.

UC Davis Health to enroll participants for major COVID-19 vaccine clinical trial

August 12, 2020

UC Davis Health has been chosen as one of only 120 sites worldwide to enroll participants for a late-stage COVID-19 vaccine study that has already shown promising results.

Brashear named to state stem cell agency’s governing board

August 12, 2020

School of Medicine Dean Allison Brashear is the newest board member of the state’s stem cell agency, the California Institute for Regenerative Medicine.

Racial, socioeconomic disparities fuel increased infant mortality rates in California

August 11, 2020

While infant mortality rates (IMR) decreased overall from 2007 to 2015 in California, disparities in infant death rates have increased in some groups, including among obese mothers, those who smoke and African American women, according to a new study published in PLOS One. 

GI symptoms linked to behavioral problems in children, especially those with autism

August 10, 2020

Common gastrointestinal symptoms are linked to troubling sleep problems, self-harm and physical complaints in preschool children. These symptoms are more common and potentially disruptive in young kids with autism.

How to support clinician engagement in quality improvement?

August 6, 2020

UC Davis Health study details the most significant factors to nurture clinicians’ self-efficacy and effectiveness in leading and engaging in QI activities.

Black patients with advanced cirrhosis are more likely to be hospitalized

August 5, 2020

A new UC Davis Health study shows that Black patients with advanced liver cirrhosis tend to be hospitalized more often and for longer periods of time than patients of other races and ethnicities. 

Two UC Davis Health experts featured in national medical journal

August 4, 2020

Nancy Lane and Garen Wintemute each have featured commentaries in the Aug. 4 issue of the Annals of Internal Medicine. Lane discusses a promising treatment for osteoarthritis. Wintemute has a call to action for health professionals to address disparities in society that are causing violence and harming health.

Music & Memory reduces dementia medications and aggressive behavior

August 3, 2020

In the most comprehensive study of its kind on the effects of the Music & Memory program, researchers from the Betty Irene Moore School of Nursing at UC Davis found personalized music reduces the amount of medication taken by nursing home residents and lessens their aggressive behaviors.

July 2020

Daniel T. O’Connor grant recipient aspires to establish clinical lactation center focused on precision medicine

July 31, 2020

This year’s Daniel T. O’Connor, M.D., Memorial Research Grant recipient is a student who is passionate about making new research discoveries in breastfeeding medicine and mammary gland biology that will benefit women and children around the world.

Insights about firearm ownership and opinion may help advance gun violence prevention policy

July 31, 2020

Understanding firearm ownership and opinion may help advance gun violence prevention policies, according to UC Davis Health researchers in a new study out today.

UC Davis Health leads in research and coordination of early psychosis programs in California

July 30, 2020

Tara Niendam has received a $2.8 million contract from the Los Angeles County Department of Mental Health in support of EPI-CAL, a network of early psychosis programs in California.

African Americans with early-life cardiovascular disease risks have worse late-life cognitive function

July 30, 2020

Research presented at the Alzheimer’s Association International Conference shows that African Americans with cardiovascular disease (CVD) risks prior to or during mid-life tend to have worse cognition when they age than those with no CVD risks.

Meet MILO, a powerful machine learning AI tool from UC Davis Health

July 29, 2020

Meet MILO, a turnkey software tool that provides a fully automated ML/AI solution to many different research and business needs.

Quitline plus surgery are big motivators for giving up smoking

July 20, 2020

Smokers who had thoracic surgery were much more likely to stop using tobacco if they also completed a quitline intervention, a new UC Davis Health study shows. 

UC Davis Health tests monoclonal antibodies as potential COVID-19 treatment

July 20, 2020

Timothy Albertson leads a new clinical trial at UC Davis Health to evaluate the efficacy, safety and tolerability of an antibody cocktail in hospitalized adult patients with COVID-19.

Study finds that special filters in glasses can help the color blind see colors better

July 13, 2020

A new UC Davis Eye Center study found that glasses engineered with spectral notch filters enhance color vision for those with the most common types of red-green color vision deficiency.

Surge in firearm purchasing during pandemic’s onset linked to higher rates of firearm violence in U.S.

July 6, 2020

A surge in firearm purchasing in the U.S. during the coronavirus pandemic – estimated to be over 2.1 million excess purchases – is linked to a significant increase in firearm violence, a study by UC Davis Violence Prevention Program suggests.

June 2020

Unexpected spectrum of mental illnesses found in patients with rare genetic disorder

June 24, 2020

UC Davis MIND Institute researchers found an unexpected spectrum of mental illnesses in patients with a rare gene mutation. These patients had a “double hit” condition that combined features and symptoms of fragile X syndrome and premutation disorder, in addition to a range of psychiatric symptoms.

Pilot grants open door to better mental health care

June 24, 2020

The Behavioral Health Center of Excellence at UC Davis recented awarded seed funding to three projects designed to improve mental health research in California and strengthen collaborations with community, regional and statewide partners.

Defining paths to possible mother to child coronavirus transmission

June 23, 2020

UC Davis Health physicians defined the conditions of viral transmission from mother to baby during pregnancy and delivery.

Male contraception clinical trial launches in Sacramento

June 22, 2020

UC Davis Health is testing a potential new birth control option that could lead to the first male hormonal birth control on the market.

UC Davis study details use of extreme risk protection orders in California over first four years

June 18, 2020

The population-based study is one of the first to detail the early use of ERPOs in California. The policies help fill a gap in violence prevention efforts by allowing individuals to intervene when someone who is not prohibited from owning a firearm poses an immediate risk of violence to themselves or others.

UC Davis Health researchers win 2020 Chancellor’s Innovation Awards

June 15, 2020

Recipients of the UC Davis 2020 Chancellor’s Innovation Awards include four UC Davis Health researchers. 

NIH grant funds a new study of infants at higher risk for ADHD and ASD

June 11, 2020

A $3.65 million grant from NIH to fund Meghan Miller’s study of autism and ADHD markers in babies.

Izumiya, Tuscano, and Siefkes receive grants to advance innovative solutions with commercial potential

June 10, 2020

Three UC Davis Health researchers will receive grants to advance research and innovations with commercial potential.

Duchenne clinical trial offers promising results using unique therapy

June 9, 2020

UC Davis Health researchers say there is promising news about a potential stem cell-related treatment for people with the progressive genetic disorder known as Duchenne’s muscular dystrophy (DMD).

Pilot grants boost COVID-19 research

June 8, 2020

The Center for Healthcare Policy and Research, Center for Health and Technology and the Behavioral Health Center of Excellence at UC Davis have collaborated to fund projects that explore the effects of the COVID-19 pandemic on mental health, breast cancer screening, NICU care, children with disabilities and post-surgery therapies.